🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our December issue, featuring a Focus on Single Cell Genomics, is now live! nature.com/neuro/volumes/…

I’m proud to have contributed (slightly) to this tour de force by Elisa Floriddia

Excited to announce that we are recruiting at our new Neurogenomics Center at Northwestern! We are looking for passionate postdoc candidates to join our team. nature.com/naturecareers/…

The team at Abrams Research Center on Neurogenomics, led by David Gate, is excited to explore their new lab! Using #ArtificialIntelligence, genetic research and global collaborations, they’re advancing Alzheimer’s disease research. #NMBetter

Spatial transcriptomics reveals distinct microglial mechanisms driving amyloid-β clearance in both passive and actively immunized #Alzheimer’s disease patients Northwestern Feinberg School of Medicine nature.com/articles/s4159…

Excited to share our latest Nature Medicine study from our new center Abrams Research Center on Neurogenomics! 🧠✨ Using spatial transcriptomics & scRNA-seq, we uncover how Aβ-targeting immunotherapies shape microglial responses in AD patient brains. A thread with our key findings is below! 🧵(1/15)

More excellent work from the brilliant Lynn van Olst. I’m a very proud PI today. More to come from Abrams Research Center on Neurogenomics!

アルツハイマー病の治療は脳自身のクリーンアップクルーにあるかもしれません nipponese.news/%e3%82%a2%e3%8…

rdcu.be/ecqZW

This video describes the findings from our recent study conducted at ⁦Abrams Research Center on Neurogenomics⁩. In the video, lead author ⁦Lynn van Olst⁩ and I discuss the findings and their implications for Alzheimer’s disease. youtu.be/pnRzktJRWAo

This Northwestern Breakthroughs podcast nicely encapsulates our study. The host does a great job leading the discussion for the lay audience to digest our work. I hope this allows people to better understand the results and impact of this study. youtu.be/bZrdwGQ_Ok0

In brains of people immunized against Aβ, postmortem omics reveal microglial plaque clearing pathways. Northwestern ow.ly/3cOl50VitbY

It’s quite an experience to have some of your favorite labs like ⁦The Colonna Lab⁩ and ⁦Haass lab⁩ comment on your lab’s research. Great reporting by Alzforum! alzforum.org/news/research-…

The Gate lab is fortunate to have such a talented scientist like Terry R Suk joining us soon. Check out his impressive work!

I am excited to present our new study out in Nature Medicine where we discover a novel synaptic protein biomarker to predict if and when someone will get Alzheimer’s disease dementia. Part 2/3 from my PhD work in the Tony Wyss-Coray lab. 🧵1/12 Full study 🔗: nature.com/articles/s4159…

We are proud to announce a collaboration with Abrams Research Center on Neurogenomics at Northwestern University Feinberg School of Medicine to harness AI for rapid discovery and innovation in Alzheimer’s disease research. Using Lens, the Center and Tempus teams will work together to uncover genomic patterns

Key to research success: ambition in vision, but pragmatism in execution. You must be guided by a long-term, ambitious goal that addresses a fundamental problem, rather than chasing incremental gains on established benchmarks. Yet, your progress should be grounded by tractable